Tags

Type your tag names separated by a space and hit enter

Tocilizumab administration in a refractory case of COVID-19.
Int J Antimicrob Agents. 2020 Aug; 56(2):106043.IJ

Authors+Show Affiliations

Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: fzh.dastan@gmail.com.Virology Research Center, National Institutes of Tuberculosis and Lung diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: sarnadji@yahoo.com.Student Research Committee, Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: alisaffaei.ss@gmail.com.Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: payamtabarsi@yahoo.com.

Pub Type(s)

Case Reports
Letter

Language

eng

PubMed ID

32502524

Citation

Dastan, Farzaneh, et al. "Tocilizumab Administration in a Refractory Case of COVID-19." International Journal of Antimicrobial Agents, vol. 56, no. 2, 2020, p. 106043.
Dastan F, Nadji SA, Saffaei A, et al. Tocilizumab administration in a refractory case of COVID-19. Int J Antimicrob Agents. 2020;56(2):106043.
Dastan, F., Nadji, S. A., Saffaei, A., & Tabarsi, P. (2020). Tocilizumab administration in a refractory case of COVID-19. International Journal of Antimicrobial Agents, 56(2), 106043. https://doi.org/10.1016/j.ijantimicag.2020.106043
Dastan F, et al. Tocilizumab Administration in a Refractory Case of COVID-19. Int J Antimicrob Agents. 2020;56(2):106043. PubMed PMID: 32502524.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Tocilizumab administration in a refractory case of COVID-19. AU - Dastan,Farzaneh, AU - Nadji,Seyed Alireza, AU - Saffaei,Ali, AU - Tabarsi,Payam, Y1 - 2020/06/02/ PY - 2020/04/09/received PY - 2020/05/16/revised PY - 2020/05/23/accepted PY - 2020/6/6/pubmed PY - 2020/8/12/medline PY - 2020/6/6/entrez SP - 106043 EP - 106043 JF - International journal of antimicrobial agents JO - Int J Antimicrob Agents VL - 56 IS - 2 SN - 1872-7913 UR - https://www.unboundmedicine.com/medline/citation/32502524/Tocilizumab_administration_in_a_refractory_case_of_COVID_19_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0924-8579(20)30213-2 DB - PRIME DP - Unbound Medicine ER -